Under healthy conditions, the PD-1/PD-L1 pathway regulates host immune homeostasis, while in inflammatory conditions, interactions between PD-1 and its ligand PD-L1 inhibit T cell responses, protecting the lesion from hyperactivated T cells in cancer [86]. The gene discussed is CD274; the disease is cancer.